7-day roundup
The 10 most notable cure or vaccine studies from the last week.
This study tested the safety and immune response of the Pfizer-BioNTech COVID-19 vaccine in healthy children aged 6 months to 12 years.
Read lead report →Phase 2 trial testing DNA vaccines against Hantaan and Puumala viruses to prevent hemorrhagic fever with renal syndrome in healthy adults.
Read report →This trial tested if the HPV vaccine works as well in girls on immunosuppressive therapy as in healthy girls. Phase 2 study with 37 participants.
Read report →A phase 3 study testing a booster shot for diphtheria, tetanus, and whooping cough in healthy Japanese adolescents aged 11-13.
Read report →This early-phase trial tests two experimental COVID-19 booster vaccines against authorized ones in 48 healthy adults, focusing on safety and immune response.
Read report →Phase 1 trial testing a new tetanus vaccine in adults 18+. Evaluates safety and immune response. 80 participants, not yet recruiting.
Read report →